Line 2,218: |
Line 2,218: |
| | | |
| ==WHO Central Nervous System Tumours (5th ed.) Content== | | ==WHO Central Nervous System Tumours (5th ed.) Content== |
− | {| class="wikitable"
| + | | class="wikitable" |
| |- | | |- |
| !'''Disease'''!!'''Page Type'''!!'''Author''' | | !'''Disease'''!!'''Page Type'''!!'''Author''' |
Line 2,227: |
Line 2,227: |
| !'''Date of Last Editor Review''' | | !'''Date of Last Editor Review''' |
| !'''Notes''' | | !'''Notes''' |
− | |- | + | |-|Astrocytoma, IDH-mutant||Disease|| |
− | | Astrocytoma, IDH-mutant||Disease|| | |
| | | | | |
| | | | | |
Line 2,237: |
Line 2,236: |
| | | | | |
| |- | | |- |
− | | Oligodendroglioma, IDH-mutant and 1p/19q-codeleted||Disease|| | + | |Oligodendroglioma, IDH-mutant and 1p/19q-codeleted||Disease|| |
| | | | | |
| | | | | |
Line 2,246: |
Line 2,245: |
| | | | | |
| |- | | |- |
− | | Glioblastoma, IDH-wildtype||Disease|| | + | |Glioblastoma, IDH-wildtype||Disease|| |
| | | | | |
| | | | | |
Line 2,255: |
Line 2,254: |
| | | | | |
| |- | | |- |
− | | Diffuse astrocytoma, MYB- or MYBL1-altered||Disease|| | + | |Diffuse astrocytoma, MYB- or MYBL1-altered||Disease|| |
| | | | | |
| | | | | |
Line 2,264: |
Line 2,263: |
| | | | | |
| |- | | |- |
− | | Angiocentric glioma||Disease|| | + | |Angiocentric glioma||Disease|| |
| | | | | |
| | | | | |
Line 2,273: |
Line 2,272: |
| | | | | |
| |- | | |- |
− | | Polymorphous low-grade neuroepithelial tumour of the young||Disease|| | + | |Polymorphous low-grade neuroepithelial tumour of the young||Disease|| |
| | | | | |
| | | | | |
Line 2,282: |
Line 2,281: |
| | | | | |
| |- | | |- |
− | | Diffuse low-grade glioma, MAPK pathway-altered ||Disease|| | + | |Diffuse low-grade glioma, MAPK pathway-altered ||Disease|| |
| | | | | |
| | | | | |
Line 2,291: |
Line 2,290: |
| | | | | |
| |- | | |- |
− | | Diffuse midline glioma, H3 K27-altered||Disease|| | + | |Diffuse midline glioma, H3 K27-altered||Disease|| |
| | | | | |
| | | | | |
Line 2,300: |
Line 2,299: |
| | | | | |
| |- | | |- |
− | | Diffuse hemispheric glioma, H3 G34-mutant||Disease|| | + | |Diffuse hemispheric glioma, H3 G34-mutant||Disease|| |
| | | | | |
| | | | | |
Line 2,309: |
Line 2,308: |
| | | | | |
| |- | | |- |
− | | Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype||Disease|| | + | |Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype||Disease|| |
| | | | | |
| | | | | |
Line 2,318: |
Line 2,317: |
| | | | | |
| |- | | |- |
− | | Infant-type hemispheric glioma||Disease|| | + | |Infant-type hemispheric glioma||Disease|| |
| | | | | |
| | | | | |
Line 2,327: |
Line 2,326: |
| | | | | |
| |- | | |- |
− | | Pilocytic astrocytoma ||Disease|| | + | |Pilocytic astrocytoma ||Disease|| |
| | | | | |
| | | | | |
Line 2,336: |
Line 2,335: |
| | | | | |
| |- | | |- |
− | | High-grade astrocytoma with piloid features||Disease|| | + | |High-grade astrocytoma with piloid features||Disease|| |
| | | | | |
| | | | | |
Line 2,345: |
Line 2,344: |
| | | | | |
| |- | | |- |
− | | Pleomorphic xanthoastrocytoma||Disease|| | + | |Pleomorphic xanthoastrocytoma||Disease|| |
| | | | | |
| | | | | |
Line 2,354: |
Line 2,353: |
| | | | | |
| |- | | |- |
− | | Subependymal giant cell astrocytoma||Disease|| | + | |Subependymal giant cell astrocytoma||Disease|| |
| | | | | |
| | | | | |
Line 2,363: |
Line 2,362: |
| | | | | |
| |- | | |- |
− | | Chordoid glioma||Disease|| | + | |Chordoid glioma||Disease|| |
| | | | | |
| | | | | |
Line 2,372: |
Line 2,371: |
| | | | | |
| |- | | |- |
− | | Astroblastoma, MN1-altered||Disease|| | + | |Astroblastoma, MN1-altered||Disease|| |
| | | | | |
| | | | | |
Line 2,381: |
Line 2,380: |
| | | | | |
| |- | | |- |
− | | Ganglioglioma||Disease|| | + | |Ganglioglioma||Disease|| |
| | | | | |
| | | | | |
Line 2,390: |
Line 2,389: |
| | | | | |
| |- | | |- |
− | | Gangliocytoma||Disease|| | + | |Gangliocytoma||Disease|| |
| | | | | |
| | | | | |
Line 2,399: |
Line 2,398: |
| | | | | |
| |- | | |- |
− | | Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma||Disease|| | + | |Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma||Disease|| |
| | | | | |
| | | | | |
Line 2,408: |
Line 2,407: |
| | | | | |
| |- | | |- |
− | | Dysembryoplastic neuroepithelial tumour||Disease|| | + | |Dysembryoplastic neuroepithelial tumour||Disease|| |
| | | | | |
| | | | | |
Line 2,417: |
Line 2,416: |
| | | | | |
| |- | | |- |
− | | Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters||Disease|| | + | |Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters||Disease|| |
| | | | | |
| | | | | |
Line 2,426: |
Line 2,425: |
| | | | | |
| |- | | |- |
− | | Papillary glioneuronal tumour||Disease|| | + | |Papillary glioneuronal tumour||Disease|| |
| | | | | |
| | | | | |
Line 2,435: |
Line 2,434: |
| | | | | |
| |- | | |- |
− | | Rosette-forming glioneuronal tumour||Disease|| | + | |Rosette-forming glioneuronal tumour||Disease|| |
| | | | | |
| | | | | |
Line 2,444: |
Line 2,443: |
| | | | | |
| |- | | |- |
− | | Myxoid glioneuronal tumour||Disease|| | + | |Myxoid glioneuronal tumour||Disease|| |
| | | | | |
| | | | | |
Line 2,453: |
Line 2,452: |
| | | | | |
| |- | | |- |
− | | Diffuse leptomeningeal glioneuronal tumour||Disease|| | + | |Diffuse leptomeningeal glioneuronal tumour||Disease|| |
| | | | | |
| | | | | |
Line 2,462: |
Line 2,461: |
| | | | | |
| |- | | |- |
− | | Multinodular and vacuolating neuronal tumour||Disease|| | + | |Multinodular and vacuolating neuronal tumour||Disease|| |
| | | | | |
| | | | | |
Line 2,471: |
Line 2,470: |
| | | | | |
| |- | | |- |
− | | Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)||Disease|| | + | |Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)||Disease|| |
| | | | | |
| | | | | |
Line 2,480: |
Line 2,479: |
| | | | | |
| |- | | |- |
− | | Central neurocytoma||Disease|| | + | |Central neurocytoma||Disease|| |
| | | | | |
| | | | | |
Line 2,489: |
Line 2,488: |
| | | | | |
| |- | | |- |
− | | Extraventricular neurocytoma||Disease|| | + | |Extraventricular neurocytoma||Disease|| |
| | | | | |
| | | | | |
Line 2,498: |
Line 2,497: |
| | | | | |
| |- | | |- |
− | | Cerebellar liponeurocytoma||Disease|| | + | |Cerebellar liponeurocytoma||Disease|| |
| | | | | |
| | | | | |
Line 2,507: |
Line 2,506: |
| | | | | |
| |- | | |- |
− | | Supratentorial ependymoma||Disease|| | + | |Supratentorial ependymoma||Disease|| |
| | | | | |
| | | | | |
Line 2,516: |
Line 2,515: |
| | | | | |
| |- | | |- |
− | | Supratentorial ependymoma, ZFTA fusion-positive ||Disease|| | + | |Supratentorial ependymoma, ZFTA fusion-positive ||Disease|| |
| | | | | |
| | | | | |
Line 2,525: |
Line 2,524: |
| | | | | |
| |- | | |- |
− | | Supratentorial ependymoma, YAP1 fusion-positive||Disease|| | + | |Supratentorial ependymoma, YAP1 fusion-positive||Disease|| |
| | | | | |
| | | | | |
Line 2,534: |
Line 2,533: |
| | | | | |
| |- | | |- |
− | | Posterior fossa ependymoma||Disease|| | + | |Posterior fossa ependymoma||Disease|| |
| | | | | |
| | | | | |
Line 2,543: |
Line 2,542: |
| | | | | |
| |- | | |- |
− | | Posterior fossa group A (PFA) ependymoma||Disease|| | + | |Posterior fossa group A (PFA) ependymoma||Disease|| |
| | | | | |
| | | | | |
Line 2,552: |
Line 2,551: |
| | | | | |
| |- | | |- |
− | | Posterior fossa group B (PFB) ependymoma||Disease|| | + | |Posterior fossa group B (PFB) ependymoma||Disease|| |
| | | | | |
| | | | | |
Line 2,561: |
Line 2,560: |
| | | | | |
| |- | | |- |
− | | Spinal ependymoma||Disease|| | + | |Spinal ependymoma||Disease|| |
| | | | | |
| | | | | |
Line 2,570: |
Line 2,569: |
| | | | | |
| |- | | |- |
− | | Spinal ependymoma, MYCN-amplified||Disease|| | + | |Spinal ependymoma, MYCN-amplified||Disease|| |
| | | | | |
| | | | | |
Line 2,579: |
Line 2,578: |
| | | | | |
| |- | | |- |
− | | Myxopapillary ependymoma||Disease|| | + | |Myxopapillary ependymoma||Disease|| |
| | | | | |
| | | | | |
Line 2,588: |
Line 2,587: |
| | | | | |
| |- | | |- |
− | | Subependymoma||Disease|| | + | |Subependymoma||Disease|| |
| | | | | |
| | | | | |
Line 2,597: |
Line 2,596: |
| | | | | |
| |- | | |- |
− | | Choroid plexus papilloma||Disease|| | + | |Choroid plexus papilloma||Disease|| |
| | | | | |
| | | | | |
Line 2,606: |
Line 2,605: |
| | | | | |
| |- | | |- |
− | | Atypical choroid plexus papilloma||Disease|| | + | |Atypical choroid plexus papilloma||Disease|| |
| | | | | |
| | | | | |
Line 2,615: |
Line 2,614: |
| | | | | |
| |- | | |- |
− | | Choroid plexus carcinoma||Disease|| | + | |Choroid plexus carcinoma||Disease|| |
| | | | | |
| | | | | |
Line 2,624: |
Line 2,623: |
| | | | | |
| |- | | |- |
− | | Medulloblastoma, WNT-activated||Disease|| | + | |Medulloblastoma, WNT-activated||Disease|| |
| | | | | |
| | | | | |
Line 2,633: |
Line 2,632: |
| | | | | |
| |- | | |- |
− | | Medulloblastoma, SHH-activated and TP53-wildtype||Disease|| | + | |Medulloblastoma, SHH-activated and TP53-wildtype||Disease|| |
| | | | | |
| | | | | |
Line 2,642: |
Line 2,641: |
| | | | | |
| |- | | |- |
− | | Medulloblastoma, SHH-activated and TP53-mutant||Disease|| | + | |Medulloblastoma, SHH-activated and TP53-mutant||Disease|| |
| | | | | |
| | | | | |
Line 2,651: |
Line 2,650: |
| | | | | |
| |- | | |- |
− | | Medulloblastoma, non-WNT/non-SHH||Disease|| | + | |Medulloblastoma, non-WNT/non-SHH||Disease|| |
| | | | | |
| | | | | |
Line 2,660: |
Line 2,659: |
| | | | | |
| |- | | |- |
− | | Medulloblastoma, histologically defined||Disease|| | + | |Medulloblastoma, histologically defined||Disease|| |
| | | | | |
| | | | | |
Line 2,669: |
Line 2,668: |
| | | | | |
| |- | | |- |
− | | Atypical teratoid/rhabdoid tumour||Disease|| | + | |Atypical teratoid/rhabdoid tumour||Disease|| |
| | | | | |
| | | | | |
Line 2,678: |
Line 2,677: |
| | | | | |
| |- | | |- |
− | | Cribriform neuroepithelial tumour||Disease|| | + | |Cribriform neuroepithelial tumour||Disease|| |
| | | | | |
| | | | | |
Line 2,687: |
Line 2,686: |
| | | | | |
| |- | | |- |
− | | Embryonal tumour with multilayered rosettes||Disease|| | + | |Embryonal tumour with multilayered rosettes||Disease|| |
| | | | | |
| | | | | |
Line 2,696: |
Line 2,695: |
| | | | | |
| |- | | |- |
− | | CNS neuroblastoma, FOXR2-activated||Disease|| | + | |CNS neuroblastoma, FOXR2-activated||Disease|| |
| | | | | |
| | | | | |
Line 2,705: |
Line 2,704: |
| | | | | |
| |- | | |- |
− | | CNS tumour with BCOR internal tandem duplication||Disease|| | + | |CNS tumour with BCOR internal tandem duplication||Disease|| |
| | | | | |
| | | | | |
Line 2,714: |
Line 2,713: |
| | | | | |
| |- | | |- |
− | | CNS embryonal tumour NEC/NOS||Disease|| | + | |CNS embryonal tumour NEC/NOS||Disease|| |
| | | | | |
| | | | | |
Line 2,723: |
Line 2,722: |
| | | | | |
| |- | | |- |
− | | Pineocytoma||Disease|| | + | |Pineocytoma||Disease|| |
| | | | | |
| | | | | |
Line 2,732: |
Line 2,731: |
| | | | | |
| |- | | |- |
− | | Pineal parenchymal tumour of intermediate differentiation||Disease|| | + | |Pineal parenchymal tumour of intermediate differentiation||Disease|| |
| | | | | |
| | | | | |
Line 2,741: |
Line 2,740: |
| | | | | |
| |- | | |- |
− | | Pineoblastoma||Disease|| | + | |Pineoblastoma||Disease|| |
| | | | | |
| | | | | |
Line 2,750: |
Line 2,749: |
| | | | | |
| |- | | |- |
− | | Papillary tumour of the pineal region||Disease|| | + | |Papillary tumour of the pineal region||Disease|| |
| | | | | |
| | | | | |
Line 2,759: |
Line 2,758: |
| | | | | |
| |- | | |- |
− | | Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant||Disease|| | + | |Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant||Disease|| |
| | | | | |
| | | | | |
Line 2,768: |
Line 2,767: |
| | | | | |
| |- | | |- |
− | | Schwannoma||Disease|| | + | |Schwannoma||Disease|| |
| | | | | |
| | | | | |
Line 2,777: |
Line 2,776: |
| | | | | |
| |- | | |- |
− | | Neurofibroma||Disease|| | + | |Neurofibroma||Disease|| |
| | | | | |
| | | | | |
Line 2,786: |
Line 2,785: |
| | | | | |
| |- | | |- |
− | | Perineurioma||Disease|| | + | |Perineurioma||Disease|| |
| | | | | |
| | | | | |
Line 2,795: |
Line 2,794: |
| | | | | |
| |- | | |- |
− | | Hybrid nerve sheath tumours||Disease|| | + | |Hybrid nerve sheath tumours||Disease|| |
| | | | | |
| | | | | |
Line 2,804: |
Line 2,803: |
| | | | | |
| |- | | |- |
− | | Malignant melanotic nerve sheath tumour||Disease|| | + | |Malignant melanotic nerve sheath tumour||Disease|| |
| | | | | |
| | | | | |
Line 2,813: |
Line 2,812: |
| | | | | |
| |- | | |- |
− | | Malignant peripheral nerve sheath tumour||Disease|| | + | |Malignant peripheral nerve sheath tumour||Disease|| |
| | | | | |
| | | | | |
Line 2,822: |
Line 2,821: |
| | | | | |
| |- | | |- |
− | | Cauda equina neuroendocrine tumour (previously paraganglioma)||Disease|| | + | |Cauda equina neuroendocrine tumour (previously paraganglioma)||Disease|| |
| | | | | |
| | | | | |
Line 2,831: |
Line 2,830: |
| | | | | |
| |- | | |- |
− | | Meningioma||Disease|| | + | |Meningioma||Disease|| |
| | | | | |
| | | | | |
Line 2,840: |
Line 2,839: |
| | | | | |
| |- | | |- |
− | | Solitary fibrous tumour||Disease|| | + | |Solitary fibrous tumour||Disease|| |
| | | | | |
| | | | | |
Line 2,849: |
Line 2,848: |
| | | | | |
| |- | | |- |
− | | Haemangiomas and vascular malformations||Disease|| | + | |Haemangiomas and vascular malformations||Disease|| |
| | | | | |
| | | | | |
Line 2,858: |
Line 2,857: |
| | | | | |
| |- | | |- |
− | | Haemangioblastoma||Disease|| | + | |Haemangioblastoma||Disease|| |
| | | | | |
| | | | | |
Line 2,867: |
Line 2,866: |
| | | | | |
| |- | | |- |
− | | Rhabdomyosarcoma||Disease|| | + | |Rhabdomyosarcoma||Disease|| |
| | | | | |
| | | | | |
Line 2,876: |
Line 2,875: |
| | | | | |
| |- | | |- |
− | | Intracranial mesenchymal tumour, FET::CREB fusion-positive||Disease|| | + | |Intracranial mesenchymal tumour, FET::CREB fusion-positive||Disease|| |
| | | | | |
| | | | | |
Line 2,885: |
Line 2,884: |
| | | | | |
| |- | | |- |
− | | CIC-rearranged sarcoma||Disease|| | + | |CIC-rearranged sarcoma||Disease|| |
| | | | | |
| | | | | |
Line 2,894: |
Line 2,893: |
| | | | | |
| |- | | |- |
− | | Primary intracranial sarcoma, DICER1-mutant||Disease|| | + | |Primary intracranial sarcoma, DICER1-mutant||Disease|| |
| | | | | |
| | | | | |
Line 2,903: |
Line 2,902: |
| | | | | |
| |- | | |- |
− | | Ewing sarcoma||Disease|| | + | |Ewing sarcoma||Disease|| |
| | | | | |
| | | | | |
Line 2,912: |
Line 2,911: |
| | | | | |
| |- | | |- |
− | | Mesenchymal chondrosarcoma||Disease|| | + | |Mesenchymal chondrosarcoma||Disease|| |
| | | | | |
| | | | | |
Line 2,921: |
Line 2,920: |
| | | | | |
| |- | | |- |
− | | Chondrosarcoma||Disease|| | + | |Chondrosarcoma||Disease|| |
| | | | | |
| | | | | |
Line 2,930: |
Line 2,929: |
| | | | | |
| |- | | |- |
− | | Chordoma||Disease|| | + | |Chordoma||Disease|| |
| | | | | |
| | | | | |
Line 2,939: |
Line 2,938: |
| | | | | |
| |- | | |- |
− | | Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis||Disease|| | + | |Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis||Disease|| |
| | | | | |
| | | | | |
Line 2,948: |
Line 2,947: |
| | | | | |
| |- | | |- |
− | | Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma||Disease|| | + | |Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma||Disease|| |
| | | | | |
| | | | | |
Line 2,957: |
Line 2,956: |
| | | | | |
| |- | | |- |
− | | Primary diffuse large B-cell lymphoma of the CNS||Disease|| | + | |Primary diffuse large B-cell lymphoma of the CNS||Disease|| |
| | | | | |
| | | | | |
Line 2,966: |
Line 2,965: |
| | | | | |
| |- | | |- |
− | | Immunodeficiency-associated CNS lymphomas||Disease|| | + | |Immunodeficiency-associated CNS lymphomas||Disease|| |
| | | | | |
| | | | | |
Line 2,975: |
Line 2,974: |
| | | | | |
| |- | | |- |
− | | Lymphomatoid granulomatosis||Disease|| | + | |Lymphomatoid granulomatosis||Disease|| |
| | | | | |
| | | | | |
Line 2,984: |
Line 2,983: |
| | | | | |
| |- | | |- |
− | | Intravascular large B-cell lymphoma||Disease|| | + | |Intravascular large B-cell lymphoma||Disease|| |
| | | | | |
| | | | | |
Line 2,993: |
Line 2,992: |
| | | | | |
| |- | | |- |
− | | MALT lymphoma of the dura||Disease|| | + | |MALT lymphoma of the dura||Disease|| |
| | | | | |
| | | | | |
Line 3,002: |
Line 3,001: |
| | | | | |
| |- | | |- |
− | | Other low-grade B-cell lymphomas of the CNS||Disease|| | + | |Other low-grade B-cell lymphomas of the CNS||Disease|| |
| | | | | |
| | | | | |
Line 3,011: |
Line 3,010: |
| | | | | |
| |- | | |- |
− | | Anaplastic large cell lymphoma (ALK+/ALK−)||Disease|| | + | |Anaplastic large cell lymphoma (ALK+/ALK−)||Disease|| |
| | | | | |
| | | | | |
Line 3,020: |
Line 3,019: |
| | | | | |
| |- | | |- |
− | | T-cell and NK/T-cell lymphomas||Disease|| | + | |T-cell and NK/T-cell lymphomas||Disease|| |
| | | | | |
| | | | | |
Line 3,029: |
Line 3,028: |
| | | | | |
| |- | | |- |
− | | Erdheim-Chester disease||Disease|| | + | |Erdheim-Chester disease||Disease|| |
| | | | | |
| | | | | |
Line 3,038: |
Line 3,037: |
| | | | | |
| |- | | |- |
− | | Rosai-Dorfman disease||Disease|| | + | |Rosai-Dorfman disease||Disease|| |
| | | | | |
| | | | | |
Line 3,047: |
Line 3,046: |
| | | | | |
| |- | | |- |
− | | Juvenile xanthogranuloma||Disease|| | + | |Juvenile xanthogranuloma||Disease|| |
| | | | | |
| | | | | |
Line 3,056: |
Line 3,055: |
| | | | | |
| |- | | |- |
− | | Langerhans cell histiocytosis||Disease|| | + | |Langerhans cell histiocytosis||Disease|| |
| | | | | |
| | | | | |
Line 3,065: |
Line 3,064: |
| | | | | |
| |- | | |- |
− | | Histiocytic sarcoma||Disease|| | + | |Histiocytic sarcoma||Disease|| |
| | | | | |
| | | | | |
Line 3,074: |
Line 3,073: |
| | | | | |
| |- | | |- |
− | | Germ cell tumours of the CNS||Disease|| | + | |Germ cell tumours of the CNS||Disease|| |
| | | | | |
| | | | | |
Line 3,083: |
Line 3,082: |
| | | | | |
| |- | | |- |
− | | Adamantinomatous craniopharyngioma||Disease|| | + | |Adamantinomatous craniopharyngioma||Disease|| |
| | | | | |
| | | | | |
Line 3,092: |
Line 3,091: |
| | | | | |
| |- | | |- |
− | | Papillary craniopharyngioma||Disease|| | + | |Papillary craniopharyngioma||Disease|| |
| | | | | |
| | | | | |
Line 3,101: |
Line 3,100: |
| | | | | |
| |- | | |- |
− | | Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma||Disease|| | + | |Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma||Disease|| |
| | | | | |
| | | | | |
Line 3,110: |
Line 3,109: |
| | | | | |
| |- | | |- |
− | | Pituitary adenoma / pituitary neuroendocrine tumour||Disease|| | + | |Pituitary adenoma / pituitary neuroendocrine tumour||Disease|| |
| | | | | |
| | | | | |
Line 3,119: |
Line 3,118: |
| | | | | |
| |- | | |- |
− | | Pituitary blastoma||Disease|| | + | |Pituitary blastoma||Disease|| |
| | | | | |
| | | | | |
Line 3,128: |
Line 3,127: |
| | | | | |
| |- | | |- |
− | | Metastases to the brain and spinal cord parenchyma||Disease|| | + | |Metastases to the brain and spinal cord parenchyma||Disease|| |
| | | | | |
| | | | | |
Line 3,137: |
Line 3,136: |
| | | | | |
| |- | | |- |
− | | Metastases to the meninges||Disease|| | + | |Metastases to the meninges||Disease|| |
| | | | | |
| | | | | |
Line 3,146: |
Line 3,145: |
| | | | | |
| |- | | |- |
− | | Neurofibromatosis type 1||Disease|| | + | |Neurofibromatosis type 1||Disease|| |
| | | | | |
| | | | | |
Line 3,155: |
Line 3,154: |
| | | | | |
| |- | | |- |
− | | Neurofibromatosis type 2||Disease|| | + | |Neurofibromatosis type 2||Disease|| |
| | | | | |
| | | | | |
Line 3,164: |
Line 3,163: |
| | | | | |
| |- | | |- |
− | | Schwannomatosis||Disease|| | + | |Schwannomatosis||Disease|| |
| | | | | |
| | | | | |
Line 3,173: |
Line 3,172: |
| | | | | |
| |- | | |- |
− | | Von Hippel-Lindau syndrome||Disease|| | + | |Von Hippel-Lindau syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,182: |
Line 3,181: |
| | | | | |
| |- | | |- |
− | | Tuberous sclerosis||Disease|| | + | |Tuberous sclerosis||Disease|| |
| | | | | |
| | | | | |
Line 3,191: |
Line 3,190: |
| | | | | |
| |- | | |- |
− | | Li-Fraumeni syndrome||Disease|| | + | |Li-Fraumeni syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,200: |
Line 3,199: |
| | | | | |
| |- | | |- |
− | | Cowden syndrome||Disease|| | + | |Cowden syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,209: |
Line 3,208: |
| | | | | |
| |- | | |- |
− | | Constitutional mismatch repair deficiency syndrome||Disease|| | + | |Constitutional mismatch repair deficiency syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,218: |
Line 3,217: |
| | | | | |
| |- | | |- |
− | | Familial adenomatous polyposis 1||Disease|| | + | |Familial adenomatous polyposis 1||Disease|| |
| | | | | |
| | | | | |
Line 3,227: |
Line 3,226: |
| | | | | |
| |- | | |- |
− | | Naevoid basal cell carcinoma syndrome||Disease|| | + | |Naevoid basal cell carcinoma syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,236: |
Line 3,235: |
| | | | | |
| |- | | |- |
− | | Rhabdoid tumour predisposition syndrome||Disease|| | + | |Rhabdoid tumour predisposition syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,245: |
Line 3,244: |
| | | | | |
| |- | | |- |
− | | Carney complex||Disease|| | + | |Carney complex||Disease|| |
| | | | | |
| | | | | |
Line 3,254: |
Line 3,253: |
| | | | | |
| |- | | |- |
− | | DICER1 syndrome||Disease|| | + | |DICER1 syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,263: |
Line 3,262: |
| | | | | |
| |- | | |- |
− | | Familial paraganglioma syndromes||Disease|| | + | |Familial paraganglioma syndromes||Disease|| |
| | | | | |
| | | | | |
Line 3,272: |
Line 3,271: |
| | | | | |
| |- | | |- |
− | | Melanoma-astrocytoma syndrome||Disease|| | + | |Melanoma-astrocytoma syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,281: |
Line 3,280: |
| | | | | |
| |- | | |- |
− | | Familial retinoblastoma||Disease|| | + | |Familial retinoblastoma||Disease|| |
| | | | | |
| | | | | |
Line 3,290: |
Line 3,289: |
| | | | | |
| |- | | |- |
− | | BAP1 tumour predisposition syndrome||Disease|| | + | |BAP1 tumour predisposition syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,299: |
Line 3,298: |
| | | | | |
| |- | | |- |
− | | Fanconi anaemia||Disease|| | + | |Fanconi anaemia||Disease|| |
| | | | | |
| | | | | |
Line 3,308: |
Line 3,307: |
| | | | | |
| |- | | |- |
− | | ELP1-medulloblastoma syndrome||Disease|| | + | |ELP1-medulloblastoma syndrome||Disease|| |
| | | | | |
| | | | | |